Spots Global Cancer Trial Database for Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
Official Title: A Phase IIIb, Multi-center, Open-label Study of RAD001 in Combination With EXemestane in Post-menopausal Women With EStrogen Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Locally Advanced or Metastatic Breast Cancer
Study ID: NCT03176238
Conditions
Study Description
Brief Summary: This international, multi-center, open-label, single-arm study evaluated the safety and tolerability profile of everolimus in post-menopausal women with HR positive, HER2 negative locally advanced or metastatic breast cancer after documented recurrence or progression following a non-steroidal aromatase inhibitors (NSAI) therapy in Novartis Oncology emergent growth market (EGM) countries.Data was presented by Asian countries vs Non-Asian countries to confirm no difference in safety and efficacy. Summary statistics were presented.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Novartis Investigative Site, Garran, Australian Capital Territory, Australia
Novartis Investigative Site, Caringbah, New South Wales, Australia
Novartis Investigative Site, Liverpool, New South Wales, Australia
Novartis Investigative Site, Box Hill, Victoria, Australia
Novartis Investigative Site, Heidelberg, Victoria, Australia
Novartis Investigative Site, Ringwood East, Victoria, Australia
Novartis Investigative Site, St Albans, Victoria, Australia
Novartis Investigative Site, Karamsad, Gujarat, India
Novartis Investigative Site, Nashik, Maharashtra, India
Novartis Investigative Site, Pune, Maharashtra, India
Novartis Investigative Site, Cuttack, Orissa, India
Novartis Investigative Site, Bandung, , Indonesia
Novartis Investigative Site, Jakarta, , Indonesia
Novartis Investigative Site, Jogyakarta, , Indonesia
Novartis Investigative Site, Semarang, , Indonesia
Novartis Investigative Site, Amman, , Jordan
Novartis Investigative Site, Suwon, Gyeonggi-do, Korea, Republic of
Novartis Investigative Site, Gyeonggi do, Korea, Korea, Republic of
Novartis Investigative Site, Seoul, Korea, Korea, Republic of
Novartis Investigative Site, Seoul, Seocho Gu, Korea, Republic of
Novartis Investigative Site, Busan, , Korea, Republic of
Novartis Investigative Site, Jeollanam-do, , Korea, Republic of
Novartis Investigative Site, Seoul, , Korea, Republic of
Novartis Investigative Site, Seoul, , Korea, Republic of
Novartis Investigative Site, Seoul, , Korea, Republic of
Novartis Investigative Site, Seoul, , Korea, Republic of
Novartis Investigative Site, Seoul, , Korea, Republic of
Novartis Investigative Site, Seoul, , Korea, Republic of
Novartis Investigative Site, Taegu, , Korea, Republic of
Novartis Investigative Site, Kuala Lumpur, MYS, Malaysia
Novartis Investigative Site, Kota Kinabalu, Sabah, Malaysia
Novartis Investigative Site, Kuala Lumpur, Wilayah Persekutuan, Malaysia
Novartis Investigative Site, Casablanca, , Morocco
Novartis Investigative Site, Rabat, , Morocco
Novartis Investigative Site, Cape Town, Western Cape, South Africa
Novartis Investigative Site, George, Western Cape, South Africa
Novartis Investigative Site, Western Cape, , South Africa
Novartis Investigative Site, New Taipei City, TWN, Taiwan
Novartis Investigative Site, Changhua, , Taiwan
Novartis Investigative Site, Kaohsiung City, , Taiwan
Novartis Investigative Site, Kaoshiung, , Taiwan
Novartis Investigative Site, Taipei, , Taiwan
Novartis Investigative Site, Taipei, , Taiwan
Novartis Investigative Site, Bangkok, , Thailand
Novartis Investigative Site, Bangkok, , Thailand
Novartis Investigative Site, Chiang Mai, , Thailand
Novartis Investigative Site, Ariana, , Tunisia
Novartis Investigative Site, Ankara, , Turkey
Novartis Investigative Site, Ankara, , Turkey
Novartis Investigative Site, Ankara, , Turkey
Novartis Investigative Site, Gaziantep, , Turkey
Novartis Investigative Site, Izmir, , Turkey
Novartis Investigative Site, Kartal, , Turkey
Novartis Investigative Site, Pendik / Istanbul, , Turkey
Novartis Investigative Site, Ho Chi Minh, , Vietnam
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
